Phytomedicine

International Journal of Phytotherapy and Phytopharmacology

Phytomedicine - ISSN 0944-7113
Source Normalized Impact per Paper (SNIP): 1.258 Source Normalized Impact per Paper (SNIP):
SNIP measures contextual citation impact by weighting citations based on the total number of citations in a subject field.
SCImago Journal Rank (SJR): 1.087 SCImago Journal Rank (SJR):
SJR is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and a qualitative measure of the journal’s impact.
Impact Factor: 3.61 (2017) Impact Factor:
The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.
© 2017 Journal Citation Reports ® (Clarivate Analytics, 2017)
5 Year Impact Factor: 3.59 (2017) Five-Year Impact Factor:
To calculate the five year Impact Factor, citations are counted in 2016 to the previous five years and divided by the source items published in the previous five years.
© 2017 Journal Citation Reports ® (Clarivate Analytics, 2017)
Volumes: Volumes 52-65
Issues: 14 issues
ISSN: 09447113

Institutional Subscription

eJournal
This journal does not feature personal pricing and is not available for personal subscription.

Secure Checkout

Personal information is secured with SSL technology.

Free Shipping

Free global shipping
No minimum order.

Description

Phytomedicine is primarily a therapy-oriented Journal. Phytomedicine publishes innovative studies on efficacy, safety, quality and mechanisms of action of specified plant extracts, phytopharmaceuticals and their isolated constituents. This includes clinical, pharmacological, pharmacokinetic, and toxicological studies of specified herbal medicinal products, herbal preparations and purified compounds which have a defined and consistent quality assuring reproducible pharmacological activity.

Phytomedicine was founded in 1994 to focus and stimulate research in this particular field and to set internationally accepted scientific standards for pharmacological studies, proof of clinical efficacy and safety of phytomedicines.

  The main aims of Phytomedicine are associated with the integration of phytopreparations into conventional/official medicine.

The journal covers the following sections:

  • Clinical pharmacology and toxicology (randomized, placebo controlled, double blind, and observational open label studies)
  • Behavioural, mental, affective, and stress-associated disorders
  • Age-associated disorders
  • Neuropharmacology
  • Endocrine pharmacology
  • Metabolic syndrome and obesity
  • Cancer
  • Immunopharmacology, inflammation
  • Infectious diseases
  • Pulmonary, gastrointestinal, cardiovascular and urogenital diseases
  • Systems biology
  • Safety assessment, pre-clinical toxicology, interaction with drugs and adverse events of herbal preparations
  • Pharmacokinetic of natural compounds
  • Standardization of herbal preparations
  • Legislation of botanicals
  • Invited reviews

The directions of Phytomedicine are known to provide profound scientific background in Herbal Medicinal Products, their reproducible Quality and evidence based therapeutic efficacy. Since then quality criteria and standardization methods were defined and the European Medical Agency has elaborated numerous guidelines for the conduction of clinical studies and preparation of Herbal Medicinal Products. In total 107 ESCOP monographs have been produced and submitted to EMA. Many new analytical methods and instruments were implemented both for analysis and standardization of herbal Substances, herbal preparations and their bioassays and tremendous work has been carried out to remain aligned with these intentions during the last 18 years.
Nowadays important topics remain to be approached, such as harmonization of the regulatory frameworks in Europe, America, Asia and Australia or the legislation of various "botanicals", where strict differentiation of requirements for health claims of herbal medicinal product, dietary supplements and nutraceuticals are required.